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We read with great interest a recent report by Mu¨hlenbruch
and colleagues [1], clearly demonstrating the dependency
of the net reclassification improvement (NRI) on risk cat-
egories. Their results underlined the recommendation to
calculate NRI based on a priori meaningful risk categories
that are linked to clinical decision-making [2, 3]. They also
reconfirmed another original recommendation to use three
categories, i.e., low, intermediate, and high risk [2].
However, many medical fields so far lack such firmly
established three-class categories, and leave room for an
arbitrary and intentional categorization for calculating NRI
in clinical studies of risk assessment. Here we address this
issue by proposing an alternative to the original NRI, which
uses a valid three-class categorization based on a familiar
concept, the likelihood ratio (LR).
Likelihood ratio is a familiar statistical methodology for
assessing the performance of a diagnostic test [4, 5]. LR
equals the fold difference of the post-test odds from the
pre-test odds, showing whether a test will provide any
meaningful change in the probability that a disease exists.
LR [ 1 indicates increased post-test probability of the
disease, and therefore a positive finding rules in a diag-
nosis. On the other hand, LR \ 1 indicates decreased post-
test probability, and thus a negative finding rules out a
diagnosis. Generally, LR for a positive finding (LR?) of at
least 2 and that for a negative finding (LR-) of at most 0.5
(i.e., 2-1) are mentioned as meaningful changes in proba-
bility [4, 5].
Here we apply this concept of LR to the risk assessment.
All we intend to do is to see whether the post-test proba-
bility of a disease is meaningfully increased from the pre-
test probability in the diseased subjects and is meaningfully
decreased in the healthy subjects. This is the very concept
of LR. When pre-test odds equal Q0 and a priori desired
LR? and LR- are [D and \D-1, the desired post-test
odds are calculated as [Q0 9 D for the positive finding
and as\Q0 9 D
-1 for the negative finding. Since the odds
correspond one-to-one with the probabilities, the desired
post-test probability can be determined by D and the pre-
test probability P0.
In a risk score with a higher predictive performance, a
larger number of subjects are expected to have the desired
post-test probability (i.e., the diseased subjects have suffi-
ciently high post-test probabilities, and the healthy subjects
have sufficiently low post-test probabilities). We can
therefore compare two risk scores by assessing which risk
score assigns more subjects with the desired post-test
probability. This is the very concept of the NRI using the
desired post-test probability for risk categorization.
To illustrate the practical use of this LR-based NRI, we
examined as an example whether adding hemoglobin A1c
(HbA1c) to fasting plasma glucose (FPG), age, and body
mass index would improve the screening performance of
diabetes mellitus (DM) in men, using a database of 1,404
male Japanese employees (UMIN000002391). All the
subjects had FPG levels\7.0 mmol/l and underwent a 75-g
oral glucose tolerance test (OGTT), revealing that 79
subjects (6 %) had DM (i.e., 120-min plasma glucose
levels C11.1 mmol/l). Note that the current example was
intended to illustrate the proposed concept, rather than
serve as a substantive analysis in search of a prediction
model. We first estimated the probability of DM in each
subject by the following two logistic regression models: a
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model in which FPG, age, and BMI were entered
(FPG ? Age ? BMI model), and a model in which HbA1c
was additionally entered (FPG ? Age ? BMI ? HbA1c
model). In the logistic regression analysis, HbA1c was
associated with the presence of DM, independently of FPG,
age and BMI (p \ 0.001); its adjusted odds ratio was 2.6
(95 %CI 2.0–3.5) per one SD (i.e., 0.5 %) increase. We
thereafter investigated whether the FPG ? Age ?
BMI ? HbA1c model had a higher predictive performance
than the FPG ? Age ? BMI model, using the LR-based
NRI. The pre-test probability P0 was 6 %, and the stan-
dards of LR ? and LR- were set as 2 and 0.5 (i.e.,
D = 2). The desired post-test probability was then calcu-
lated as [11 % for the positive finding and \3 % for the
negative finding. We therefore defined the risk categories
of the post-test probability as follows: ‘‘low risk’’ (\3 %),
‘‘intermediate risk’’ (3–11 %), and ‘‘high risk’’ ([11 %).
Table 1 is the reclassification table based on the LR-based
categorization. The NRI of the FPG ? Age ? BMI ?
HbA1c model from the FPG ? Age ? BMI model was
?0.161 (p = 0.004) for the overall population, ?0.063
(p = 0.251) for the diabetic subjects, and ?0.098
(p \ 0.001) for the non-diabetic subjects [2]. Note that the
increment in the C statistic was ?0.034 (p = 0.005), from
0.883 in the FPG ? Age ? BMI model and 0.917 in the
FPG ? Age ? BMI ? HbA1c model.
In this letter, we propose the LR-based NRI, as an alterna-
tive to the original NRI [2]. The LR-based NRI preserves the
use of categories, or, in other words, its calculation is based
on three-category ‘‘classification,’’ without losing the original
concept of ‘‘reclassification.’’ This is in contrast to the con-
tinuous (i.e., category-free) NRI, another and a well-estab-
lished alternative to the original NRI. In the current example,
the pre-test probability P0 was derived from the prevalence of
the outcome in the study sample. However, it may be valid to
use a known value of the target population in some demands. In
addition, we used LR? of 2 and LR- of 0.5 in the example, but
in some scenarios, other standards (e.g., 5 or 10 of LR?, and
0.2 or 0.1 of LR-) might be used if there is a good reason.
When researchers demonstrate the LR-based NRI, the clear
statement of which standards of LR they use will be required.
The statement will help the readers correctly interpret their
findings, on the basis of the established understanding of LR.
LR is a familiar concept and would be a common language
between the researchers and the readers, in discussion of
whether the LR standards are valid. This is considered an
advantage of using the concept of LR.
In conclusion, we proposed an NRI based on the concept
of LR, with potential use in various fields requiring risk
assessment.
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Table 1 Reclassification by the addition of HbA1c in the risk assessment for OGTT-detected DM in men







Subjects with OGTT-detected DM (n = 79)
FPG ? Age ? BMI model
Low risk (\3 %) 3 (4 %) 5 (6 %) 1 (1 %)
Intermediate risk (3–11 %) 2 (3 %) 5 (6 %) 6 (8 %)
High risk ([11 %) 0 (0 %) 5 (6 %) 52 (66 %)
Subjects without OGTT-detected DM (n = 1,325)
FPG ? Age ? BMI model
Low risk (\3 %) 857 (65 %) 37 (3 %) 1 (0 %)
Intermediate risk (3–11 %) 129 (10 %) 131 (10 %) 18 (1 %)
High risk ([11 %) 3 (0 %) 54 (4 %) 95 (7 %)
Data are number (percentage) of subjects. High risk ([11 %) was equivalent to the post-test probability providing LR larger than 2, whereas low
risk (\3 %) was that providing LR smaller than 0.5 (i.e., 2-1). The NRI of the FPG ? Age ? BMI ? HbA1c model from the FPG ?
Age ? BMI model was ?0.161 (p = 0.004) for the overall population, ?0.063 (p = 0.251) for subjects with OGTT-detected DM, and ?0.098
(p \ 0.001) for those without it [2]. To demonstrate the current example, we used a database of male Japanese employees in the Amagasaki
Visceral Fat Study (UMIN000002391). Approval of the human ethics committee of Osaka University, and written informed consent from every
participant were obtained
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